Recently accredited as the first GMP-compliant contract development and manufacturing organization (CDMO) in the Indian Ocean, Biolabex provides cosmetics, pharmaceutical, and nutraceutical companies with a full spectrum of R&D and consulting services—early development, formulation, manufacturing, concept marketing, regulatory affairs, and compliance audits.
“Mauritius is widely regarded as one of the world’s biodiversity hotspots and we saw great potential in locating our first laboratory here,” said Marc Labiche, CEO of Biolabex. “We also have an office in Paris, and this dual presence allows Biolabex, and its clients, to draw benefits from the best of both worlds—close proximity to a rich source of active ingredients, and to leading players in the pharmaceutical and cosmetics industries. These factors place Biolabex in a prime position to serve as a global hub.”
To date, Biolabex has collaborated with a number of key clients, including one of dermatology sector’s largest players.
“For now, our focus is on the cosmetics, pharmaceutical and nutraceutical market in Europe and US, before looking towards promising markets such as Africa and Asia. Our future plans include expansion of our clientele to other industries, such as medical devices, food supplements, and agriculture,” said Labiche.
More info: www.biolabex.com